$8.04
0.50% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
US3984384087
Symbol
GRFS
Sector
Industry

Grifols, S.A. Sponsored ADR Class B Stock price

$8.04
+1.03 14.69% 1M
-0.56 6.51% 6M
+0.60 8.06% YTD
+0.36 4.69% 1Y
-5.03 38.49% 3Y
-12.31 60.49% 5Y
-8.32 50.86% 10Y
Nasdaq, Closing price Tue, May 20 2025
+0.04 0.50%
ISIN
US3984384087
Symbol
GRFS
Sector
Industry

Key metrics

Market capitalization $2.08b
Enterprise Value $14.98b
P/E (TTM) P/E ratio 26.14
EV/FCF (TTM) EV/FCF 14.47
EV/Sales (TTM) EV/Sales 1.89
P/S ratio (TTM) P/S ratio 0.26
P/B ratio (TTM) P/B ratio 0.90
Revenue growth (TTM) Revenue growth 9.67%
Revenue (TTM) Revenue $7.91b
EBIT (operating result TTM) EBIT $1.32b
Free Cash Flow (TTM) Free Cash Flow $1.04b
Cash position $813.19m
EPS (TTM) EPS $0.31
P/E forward 10.43
P/S forward 0.25
EV/Sales forward 1.78
Short interest 0.40%
Show more

Is Grifols, S.A. Sponsored ADR Class B a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Grifols, S.A. Sponsored ADR Class B Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Grifols, S.A. Sponsored ADR Class B forecast:

1x Buy
33%
1x Hold
33%
1x Sell
33%

Analyst Opinions

3 Analysts have issued a Grifols, S.A. Sponsored ADR Class B forecast:

Buy
33%
Hold
33%
Sell
33%

Financial data from Grifols, S.A. Sponsored ADR Class B

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
7,914 7,914
10% 10%
100%
- Direct Costs 4,898 4,898
11% 11%
62%
3,015 3,015
8% 8%
38%
- Selling and Administrative Expenses 828 828
12% 12%
10%
- Research and Development Expense 394 394
5% 5%
5%
1,793 1,793
25% 25%
23%
- Depreciation and Amortization 475 475
3% 3%
6%
EBIT (Operating Income) EBIT 1,318 1,318
35% 35%
17%
Net Profit 209 209
2% 2%
3%

In millions USD.

Don't miss a Thing! We will send you all news about Grifols, S.A. Sponsored ADR Class B directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Grifols, S.A. Sponsored ADR Class B Stock News

Neutral
Seeking Alpha
8 days ago
Grifols, S.A. (NASDAQ:GRFS ) Q1 2025 Earnings Conference Call May 12, 2025 12:30 PM ET Company Participants Danny Segarra - VP, IR and Sustainability Nacho Abia - CEO Rahul Srinivasan - CFO Roland Wandeler - President Biopharma Conference Call Participants Charles Pitman - Barclays Alvaro Lenze - Alantra Equities Jaime Escribano - Banco Santander Guilherme Sampaio - CaixaBank Danny Segarra Hell...
Positive
Reuters
8 days ago
Grifols's net profit almost tripled from a year earlier, which the Spanish drugmaker said reinforced its confidence in meeting its full-year guidance.
Neutral
Business Wire
about one month ago
MÄNNEDORF, Switzerland--(BUSINESS WIRE)--IBL International GmbH, a Tecan company, which develops, manufactures and offers specialty diagnostics, today announced a strategic partnership with Grifols, a global healthcare company and leading producer of plasma-derived medicines and innovative diagnostic solutions, to transform the specialty diagnostics market. Under this collaboration, IBL will de...
More Grifols, S.A. Sponsored ADR Class B News

Company Profile

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

Head office Spain
CEO Nacho Abia
Employees 23,833
Founded 1940
Website www.grifols.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today